Loss of caveolin-3 induces a lactogenic microenvironment that is protective against mammary tumor formation

American Journal of Pathology

Volumn 174, Issue 2, 2009, Pages 613-629

  Sotgia, Federica ^a,b,c,d   Casimiro, Mathew C ^a,b   Bonuccelli, Gloria ^a,b   Liu, Manran ^a,b   Whitaker Menezes, Diana ^a,b   Er, Ozlem ^a,b   Daumer, Kristin M ^a,b   Mercier, Isabelle ^a,b   Witkiewicz, Agnieszka K ^c   Minetti, Carlo ^a,b   Capozza, Franco ^d   Gormley, Michael ^a,b   Quong, Andrew A ^a,b   Rui, Hallgeir ^a,b   Frank, Philippe G ^a,b   Milliman, Janet N ^a,b   Knudsen, Erik S ^a,b   Zhou, Jie ^a,b   Wang, Chenguang ^a,b   Pestell, Richard G ^a,b   Lisanti, Michael P ^a,b,c,d   more..

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 3; MYC PROTEIN; SCATTER FACTOR; STAT5A PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELF5; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST MILK; CANCER INHIBITION; CANCER PREVENTION; CARCINOGENESIS; CELL MIGRATION; CONTROLLED STUDY; FEMALE; LACTATION; LUNG METASTASIS; MALE; MAMMARY GLAND; MILK PRODUCTION; MOUSE; MYOEPITHELIUM CELL; NONHUMAN; PARACRINE SIGNALING; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

EID: 59649087892     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080653     Document Type: Article

References (83)

1. Innes KE, Byers TE: First pregnancy characteristics and subsequent breast cancer risk among young women. Int J Cancer 2004, 112:306-311
2. MacMahon B, Cole P, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S: Age at first birth and breast cancer risk. Bull World Health Organ 1970, 43:209-221
3. MacMahon B, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Trichopoulos D, Valaoras VG, Yuasa S: Lactation and cancer of the breast. A summary of an international study. Bull World Health Organ 1970, 42:185-194
4. Trichopoulos D, Hsieh CC, MacMahon B, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S: Age at any birth and breast cancer risk. Int J Cancer 1983, 31:701-704
5. Henderson BE, Powell D, Rosario I, Keys C, Hanisch R, Young M, Casagrande J, Gerkins V, Pike MC: An epidemiologic study of breast cancer. J Natl Cancer Inst 1974, 53:609-614
6. Kelsey JL, Gammon MD: Epidemiology of breast cancer. Epidemiol Rev 1990, 12:228-240
7. Kelsey JL, Gammon MD: The epidemiology of breast cancer. CA Cancer J Clin 1991, 41:146-165
8. Kelsey JL, Gammon MD, John EM: Reproductive factors and breast cancer. Epidemiol Rev 1993, 15:36-47
9. Britt K, Ashworth A, Smalley M: Pregnancy and the risk of breast cancer. Endocr Relat Cancer 2007, 14:907-933
10. Lord SJ, Bernstein L, Johnson KA, Malone KE, McDonald JA, Marchbanks PA, Simon MS, Strom BL, Press MF, Folger SG, Burkman RT, Deapen D, Spirtas R, Ursin G: Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: a case-control study. Cancer Epidemiol Biomarkers Prev 2008, 17:1723-1730
11. Ma H, Bernstein L, Pike MC, Ursin G: Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 2006, 8:R43
12. Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, Daling JR, Norman SA, Liff JM, Marchbanks PA, Folger SG, Simon MS, Strom BL, Burkman RT, Weiss LK, Spirtas R: Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer 2005, 93:364-371
13. Galbiati F, Engelman JA, Volonte D, Zhang XL, Minetti C, Li M, Hou H, Kneitz B, Edelmann W, Lisanti MP: Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities. J Biol Chem 2001, 276:21425-21433
14. Park DS, Lee H, Frank PG, Razani B, Nguyen AV, Parlow AF, Russell RG, Hulit J, Pestell RG, Lisanti MP: Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade. Mol Biol Cell 2002, 13:3416-3430
15. Williams TM, Cheung MW, Park DS, Razani B, Cohen AW, Muller WJ, Di Vizio D, Chopra NG, Pestell RG, Lisanti MP: Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice. Mol Biol Cell 2003, 14:1027-1042
16. Williams TM, Sotgia F, Lee H, Hassan G, Di Vizio D, Bonuccelli G, Capozza F, Mercier I, Rui H, Pestell RG, Lisanti MP: Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells. Am J Pathol 2006, 169:1784-1801
17. Li Z, Wang C, Jiao X, Katiyar S, Casimiro MC, Prendergast GC, Powell MJ, Pestell RG: Alternate cyclin D1 mRNA splicing modulates p27KIP1 binding and cell migration. J Biol Chem 2008, 283:7007-7015
18. Lemay DG, Neville MC, Rudolph MC, Pollard KS, German JB: Gene regulatory networks in lactation: identification of global principles using bioinformatics. BMC Syst Biol 2007, 1:56
19. Blakely CM, Stoddard AJ, Belka GK, Dugan KD, Notarfrancesco KL, Moody SE, D'Cruz CM, Chodosh LA: Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Res 2006, 66:6421-6431
20. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, Weinberg RA: An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008, 40:499-507
21. Cui Y, Zhou M, Wong WH: Integrated analysis of microarray data and gene function information. Omics 2004, 8:106-117
22. Edelman E, Porrello A, Guinney J, Balakumaran B, Bild A, Febbo PG, Mukherjee S: Analysis of sample set enrichment scores: assaying the enrichment of sets of genes for individual samples in genome-wide expression profiles. Bioinformatics 2006, 22:e108-e116
23. Sotgia F, Williams TM, Cohen AW, Minetti C, Pestell RG, Lisanti MP: Caveolin-1-deficient mice have an increased mammary stem cell population with upregulation of Wnt/beta-catenin signaling. Cell Cycle 2005, 4:1808-1816
24. Li T, Sotgia F, Vuolo MA, Li M, Yang WC, Pestell RG, Sparano JA, Lisanti MP: Caveolin-1 mutations in human breast cancer: functional association with estrogen receptor alpha-positive status. Am J Pathol 2006, 168:1998-2013
25. Guy CT, Cardiff RD, Muller WJ: Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992, 12:954-961
26. Williams TM, Medina F, Badano I, Hazan RB, Hutchinson J, Muller WJ, Chopra NG, Scherer PE, Pestell RG, Lisanti MP: Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo: role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 2004, 279:51630-51646
27. Bourguignon LY, Gunja-Smith Z, Iida N, Zhu HB, Young LJ, Muller WJ, Cardiff RD: CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol 1998, 176:206-215
28. Borowsky AD, Namba R, Young LJ, Hunter KW, Hodgson JG, Tepper CG, McGoldrick ET, Muller WJ, Cardiff RD, Gregg JP: Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior. Clin Exp Metastasis 2005, 22:47-59
29. Tang Z-L, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, Lisanti MP: Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 1996, 271:2255-2261
30. Song KS, Scherer PE, Tang Z-L, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, Lisanti MP: Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 1996, 271:15160-15165
31. Lee H, Park DS, Razani B, Russell RG, Pestell RG, Lisanti MP: Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia. Am J Pathol 2002, 161:1357-1369
32. Razani B, Combs TP, Wang XB, Frank PG, Park DS, Russell RG, Li M, Tang B, Jelicks LA, Scherer PE, Lisanti MP: Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J Biol Chem 2002, 277:8635-8647
33. Williams CC, Allison JG, Vidal GA, Burow ME, Beckman BS, Marrero L, Jones FE: The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J Cell Biol 2004, 167:469-478
34. Price-Schiavi SA, Andrechek E, Idris N, Li P, Rong M, Zhang J, Carothers Carraway CA, Muller WJ, Carraway KL: Expression, location, and interactions of ErbB2 and its intramembrane ligand Muc4 (sialomucin complex) in rat mammary gland during pregnancy. J Cell Physiol 2005, 203:44-53
35. Kuorelahti A, Rulli S, Huhtaniemi I, Poutanen M: Human chorionic gonadotropin (hCG) up-regulates wnt5b and wnt7b in the mammary gland, and hCGbeta transgenic female mice present with mammary gland tumors exhibiting characteristics of the Wnt/beta-catenin pathway activation. Endocrinology 2007, 148:3694-3703
36. Oakes SR, Naylor MJ, Asselin-Labat ML, Blazek KD, Gardiner-Garden M, Hilton HN, Kazlauskas M, Pritchard MA, Chodosh LA, Pfeffer PL, Lindeman GJ, Visvader JE, Ormandy CJ: The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes Dev 2008, 22:581-586
37. Hennighausen L, Robinson GW: Information networks in the mammary gland. Nat Rev Mol Cell Biol 2005, 6:715-725
38. Lewis MT, Ross S, Strickland PA, Snyder CJ, Daniel CW: Regulated expression patterns of IRX-2, an Iroquois-class homeobox gene, in the human breast. Cell Tissue Res 1999, 296:549-554
39. Wagner KU, Smith GH: Pregnancy and stem cell behavior. J Mammary Gland Biol Neoplasia 2005, 10:25-36
40. Pollard JW: Tumour-stromal interactions: transforming growth factor-beta isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis. Breast Cancer Res 2001, 3:230-237
41. Soriano JV, Pepper MS, Orci L, Montesano R: Roles of hepatocyte growth factor/scatter factor and transforming growth factor-beta1 in mammary gland ductal morphogenesis. J Mammary Gland Biol Neoplasia 1998, 3:133-150
42. Andrechek ER, Mori S, Rempel RE, Chang JT, Nevins JR: Patterns of cell signaling pathway activation that characterize mammary development. Development 2008, 135:2403-2413
43. Boiani M, Scholer HR: Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol 2005, 6:872-884
44. Li H, Cherukuri P, Li N, Cowling V, Spinella M, Cole M, Godwin AK, Wells W, DiRenzo J: Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Res 2007, 67:501-510
45. Christner PJ, Jimenez SA: Animal models of systemic sclerosis: insights into systemic sclerosis pathogenesis and potential therapeutic approaches. Curr Opin Rheumatol 2004, 16:746-752
46. Shyamala G, Schneider W, Schott D: Developmental regulation of murine mammary progesterone receptor gene expression. Endocrinology 1990, 126:2882-2889
47. Mohla S, Clem-Jackson N, Hunter JB: Estrogen receptors and estrogen-induced gene expression in the rat mammary glands and uteri during pregnancy and lactation: changes in progesterone receptor and RNA polymerase activity. J Steroid Biochem 1981, 14:501-508
48. Iavnilovitch E, Eilon T, Groner B, Barash I: Expression of a carboxy terminally truncated Stat5 with no transactivation domain in the mammary glands of transgenic mice inhibits cell proliferation during pregnancy, delays onset of milk secretion, and induces apoptosis upon involution. Mol Reprod Dev 2006, 73:841-849
49. Iavnilovitch E, Groner B, Barash I: Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis. Mol Cancer Res 2002, 1:32-47
50. Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ, Pollard JW: Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 2003, 163:2113-2126
51. Maglione JE, Moghanaki D, Young LJ, Manner CK, Ellies LG, Joseph SO, Nicholson B, Cardiff RD, MacLeod CL: Transgenic polyoma middle-T mice model premalignant mammary disease. Cancer Res 2001, 61:8298-8305
52. Zhou J, Chehab R, Tkalcevic J, Naylor MJ, Harris J, Wilson TJ, Tsao S, Tellis I, Zavarsek S, Xu D, Lapinskas EJ, Visvader J, Lindeman GJ, Thomas R, Ormandy CJ, Hertzog PJ, Kola I, Pritchard MA: Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactation. EMBO J 2005, 24:635-644
53. Liu X, Robinson GW, Wagner KU, Garrett L, Wynshaw-Boris A, Hennighausen L: Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev 1997, 11:179-186
54. Blakely CM, Sintasath L, D'Cruz CM, Hahn KT, Dugan KD, Belka GK, Chodosh LA: Developmental stage determines the effects of MYC in the mammary epithelium. Development 2005, 132:1147-1160
55. Locke D, Jamieson S, Stein T, Liu J, Hodgins MB, Harris AL, Gusterson B: Nature of Cx30-containing channels in the adult mouse mammary gland. Cell Tissue Res 2007, 328:97-107
56. Robinson GW, McKnight RA, Smith GH, Hennighausen L: Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development 1995, 121:2079-2090
57. Kannius-Janson M, Lidberg U, Hulten K, Gritli-Linde A, Bjursell G, Nilsson J: Studies of the regulation of the mouse carboxyl ester lipase gene in mammary gland. Biochem J 1998, 336:577-585
58. Jasmin JF, Mercier I, Sotgia F, Lisanti MP: SOCS proteins and caveolin-1 as negative regulators of endocrine signaling. Trends Endocrinol Metab 2006, 17:150-158
59. Galbiati F, Volonte D, Liu J, Capozza F, Frank PG, Zhu L, Pestell RG, Lisanti MP: Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol Biol Cell 2001, 12:2229-2244
60. Tonetti DA: Prevention of breast cancer by recapitulation of pregnancy hormone levels. Breast Cancer Res 2004, 6:E8
61. Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X, Nandi S: Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci USA 1999, 96:2520-2525
62. Russo J, Russo IH: Hormonally induced differentiation: a novel approach to breast cancer prevention. J Cell Biochem Suppl 1995, 22:58-64
63. Rajkumar L, Guzman RC, Yang J, Thordarson G, Talamantes F, Nandi S: Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments. Breast Cancer Res 2004, 6:R31-R37
64. Armogida SA, Yannaras NM, Melton AL, Srivastava MD: Identification and quantification of innate immune system mediators in human breast milk. Allergy Asthma Proc 2004, 25:297-304
65. Stroinigg N, Srivastava MD: Modulation of toll-like receptor 7 and LL-37 expression in colon and breast epithelial cells by human beta-defensin-2. Allergy Asthma Proc 2005, 26:299-309
66. Kverka M, Burianova J, Lodinova-Zadnikova R, Kocourkova I, Cinova J, Tuckova L, Tlaskalova-Hogenova H: Cytokine profiling in human colostrum and milk by protein array. Clin Chem 2007, 53:955-962
67. Goldman AS, Chheda S, Garofalo R, Schmalstieg FC: Cytokines in human milk: properties and potential effects upon the mammary gland and the neonate. J Mammary Gland Biol Neoplasia 1996, 1:251-258
68. Yang Y, Spitzer E, Kenney N, Zschiesche W, Li M, Kromminga A, Muller T, Spener F, Lezius A, Veerkamp JH, Smith GH, Salomon DS, Grosse R: Members of the fatty acid binding protein family are differentiation factors for the mammary gland. J Cell Biol 1994, 127:1097-1109
69. Baltzer A, Svanborg C, Jaggi R: Apoptotic cell death in the lactating mammary gland is enhanced by a folding variant of alpha-lactalbumin. Cell Mol Life Sci 2004, 61:1221-1228
70. Furlong SJ, Mader JS, Hoskin DW: Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen. Oncol Rep 2006, 15:1385-1390
71. Breton M, Mariller C, Benaissa M, Caillaux K, Browaeys E, Masson M, Vilain JP, Mazurier J, Pierce A: Expression of delta-lactoferrin induces cell cycle arrest. Biometals 2004, 17:325-329
72. Nukumi N, Iwamori T, Kano K, Naito K, Tojo H: Whey acidic protein (WAP) regulates the proliferation of mammary epithelial cells by preventing serine protease from degrading laminin. J Cell Physiol 2007, 213:793-800
73. Rodriguez AO, Chew H, Cress R, Xing G, McElvy S, Danielsen B, Smith L: Evidence of poorer survival in pregnancy-associated breast cancer. Obstet Gynecol 2008, 112:71-78
74. Chessa S, Chiatti F, Ceriotti G, Caroli A, Consolandi C, Pagnacco G, Castiglioni B: Development of a single nucleotide polymorphism genotyping microarray platform for the identification of bovine milk protein genetic polymorphisms. J Dairy Sci 2007, 90:451-464
75. Prinzenberg EM, Weimann C, Brandt H, Bennewitz J, Kalm E, Schwerin M, Erhardt G: Polymorphism of the bovine CSN1S1 promoter: linkage mapping, intragenic haplotypes, and effects on milk production traits. J Dairy Sci 2003, 86:2696-2705
76. Bovenhuis H, Van Arendonk JA, Korver S: Associations between milk protein polymorphisms and milk production traits. J Dairy Sci 1992, 75:2549-2559
77. Ikonen T, Bovenhuis H, Ojala M, Ruottinen O, Georges M: Associations between casein haplotypes and first lactation milk production traits in Finnish Ayrshire cows. J Dairy Sci 2001, 84:507-514
78. Cosenza G, Pauciullo A, Colimoro L, Mancusi A, Rando A, Di Berardino D, Ramunno L: An SNP in the goat CSN2 promoter region is associated with the absence of beta-casein in milk. Anim Genet 2007, 38:655-658
79. Ramunno L, Longobardi E, Pappalardo M, Rando A, Di Gregorio P, Cosenza G, Mariani P, Pastore N, Masina P: An allele associated with a non-detectable amount of alpha s2 casein in goat milk. Anim Genet 2001, 32:19-26
80. Cosenza G, Gallo D, Illario R, di Gregorio P, Senese C, Ferrara L, Ramunno L: A Mval PCR-RFLP detecting a silent allele at the goat alpha-lactalbumin locus. J Dairy Res 2003, 70:355-357
81. Hajjoubi S, Rival-Gervier S, Hayes H, Floriot S, Eggen A, Piumi F, Chardon P, Houdebine LM, Thepot D: Ruminants genome no longer contains whey acidic protein gene but only a pseudogene. Gene 2006, 370:104-112
82. Prinzenberg EM, Gutscher K, Chessa S, Caroli A, Erhardt G: Caprine kappa-casein (CSN3) polymorphism: new developments in molecular knowledge. J Dairy Sci 2005, 88:1490-1498
83. Persuy MA, Printz C, Medrano JF, Mercier JC: A single nucleotide deletion resulting in a premature stop codon is associated with marked reduction of transcripts from a goat beta-casein null allele. Anim Genet 1999, 30:444-451